Literature DB >> 11027493

Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3).

M Kojima1, R Haruno, M Nakazato, Y Date, N Murakami, R Hanada, H Matsuo, K Kangawa.   

Abstract

GPR66 is an orphan G-protein-coupled receptor (GPCR) whose structure is similar to the ghrelin and motilin receptors. We have tried to purify a natural ligand for GPR66 in rat tissues and identified a 23-amino-acid peptide as the endogenous ligand. Sequence analysis revealed the peptide as neuromedin U (NMU), a smooth-muscle-contracting peptide that was first purified from porcine spinal cord by our group. NMU binds to GPR66-expressing cells with high specificity to induce intracellular calcium mobilization. When NMU was injected intracerebroventricularly (ICV) into rats, it potently suppressed food intake. In contrast, ICV injection of NMU-antibody increased food intake. These results suggest that NMU is a potent endogenous anorexic peptide. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027493     DOI: 10.1006/bbrc.2000.3502

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc.

Authors:  Seiji Sato; Xi-Ping Huang; Wesley K Kroeze; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2016-10-17       Impact factor: 4.436

2.  Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites.

Authors:  Kentaro Takayama; Kenji Mori; Yuko Sohma; Koji Taketa; Akihiro Taguchi; Fumika Yakushiji; Naoto Minamino; Mikiya Miyazato; Kenji Kangawa; Yoshio Hayashi
Journal:  ACS Med Chem Lett       Date:  2015-01-28       Impact factor: 4.345

3.  Effects of peripheral administration of a Neuromedin U receptor 2-selective agonist on food intake and body weight in obese mice.

Authors:  T Kaisho; H Nagai; T Asakawa; N Suzuki; H Fujita; K Matsumiya; N Nishizawa; Y Kanematsu-Yamaki; K Dote; J-I Sakamoto; T Asami; S Takekawa
Journal:  Int J Obes (Lond)       Date:  2017-07-31       Impact factor: 5.095

4.  The c-Myb target gene neuromedin U functions as a novel cofactor during the early stages of erythropoiesis.

Authors:  Julia E Gambone; Stephanie S Dusaban; Roxana Loperena; Yuji Nakata; Susan E Shetzline
Journal:  Blood       Date:  2011-03-04       Impact factor: 22.113

5.  Neuromedin U receptor 2-deficient mice display differential responses in sensory perception, stress, and feeding.

Authors:  Hongkui Zeng; Alexander Gragerov; John G Hohmann; Maria N Pavlova; Brian A Schimpf; Hui Xu; Long-Jun Wu; Hiroki Toyoda; Ming-Gao Zhao; Alex D Rohde; Galina Gragerova; Rene Onrust; John E Bergmann; Min Zhuo; George A Gaitanaris
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

6.  Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem.

Authors:  M Niimi; K Murao; T Taminato
Journal:  Endocrine       Date:  2001-12       Impact factor: 3.633

7.  Identification of neuromedin S and its possible role in the mammalian circadian oscillator system.

Authors:  Kenji Mori; Mikiya Miyazato; Takanori Ida; Noboru Murakami; Ryota Serino; Yoichi Ueta; Masayasu Kojima; Kenji Kangawa
Journal:  EMBO J       Date:  2005-01-06       Impact factor: 11.598

Review 8.  Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S.

Authors:  J D Mitchell; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2009-06-10       Impact factor: 8.739

9.  Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats.

Authors:  Jane Gartlon; Philip Szekeres; Mark Pullen; Henry M Sarau; Nambi Aiyar; Usman Shabon; David Michalovich; Klaudia Steplewski; Cathy Ellis; Nabil Elshourbagy; Mark Duxon; Tracey E Ashmeade; David C Harrison; Paul Murdock; Shelagh Wilson; Abdel Ennaceur; Alan Atkins; Christian Heidbreder; Jim J Hagan; A Jackie Hunter; Declan N C Jones
Journal:  Psychopharmacology (Berl)       Date:  2004-06-16       Impact factor: 4.530

10.  The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2).

Authors:  Andrea Peier; Jennifer Kosinski; Kimberly Cox-York; Ying Qian; Kunal Desai; Yue Feng; Prashant Trivedi; Nicholas Hastings; Donald J Marsh
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.